Apparent and true resistant hypertension: definition, prevalence and outcomes.
Judd E, Calhoun DA.
J Hum Hypertens. 2014 Aug;28(8):463-8. doi: 10.1038/jhh.2013.140. Epub 2014 Jan 16.
Pseudo and resistant hypertension: A chaotic perspective.
Moreno H.
J Clin Hypertens (Greenwich). 2022 Jun;24(6):698-703. doi: 10.1111/jch.14486. Epub 2022 Apr 25.
Resistant Hypertension: Novel Insights.
Lamirault G, Artifoni M, Daniel M, Barber-Chamoux N, Nantes University Hospital Working Group On Hypertension.
Curr Hypertens Rev. 2020;16(1):61-72. doi: 10.2174/1573402115666191011111402.
Hypertension in Chronic Kidney Disease.
Hamrahian SM, Falkner B.
Adv Exp Med Biol. 2017;956:307-325. doi: 10.1007/5584_2016_84.
Pseudo hypertension of youth: too much of a good thing?
Cockcroft JR, McEniery CM, Wilkinson IB.
Am J Hypertens. 2003 Mar;16(3):262-4. doi: 10.1016/s0895-7061(02)03264-8.
Pseudo-hypertension and arterial stiffness: a review.
Foran TG, Sheahan NF, Cunningham C, Feely J.
Physiol Meas. 2004 Apr;25(2):R21-33. doi: 10.1088/0967-3334/25/2/r02.
Pseudo-hypertension in the elderly: still hazy, after all these years.
Spence JD.
J Hum Hypertens. 1997 Oct;11(10):621-3. doi: 10.1038/sj.jhh.1000529.
Evaluation of the relationship between pseudo-hypertension and the parameters of subclinical atherosclerosis.
Karabiyik U, Savas G, Yasan M, Murat Bucak H, Cesur B, Cetinkaya Z, Topsakal R, Dogan A.
Blood Press Monit. 2021 Feb 1;26(1):1-7. doi: 10.1097/MBP.0000000000000490.
Electrocardiographic differences in patients with true and pseudo-resistant hypertension.
Eyuboglu M, Acikel B.
J Hum Hypertens. 2022 Jul;36(7):622-628. doi: 10.1038/s41371-021-00559-8. Epub 2021 Jun 15.
Syndromes of Pseudo-Hyperaldosteronism.
Rizzolo K, Beck NM, Ambruso SL.
Clin J Am Soc Nephrol. 2022 Apr;17(4):581-584. doi: 10.2215/CJN.14201021. Epub 2022 Feb 8.
